SN
Santen Pharmaceutical Co., Ltd.
SNPHF · OTC
$13.05 +0.00% (+$0.00)
Market Cap ¥644.7B
P/E Ratio 16.60x
Div. Yield 1.90%
ROE 17.61%
Bulios Fair Price
$14.21
8.9% upside
Trenutna cena
$13.05
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SNPHF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
79 /100
Cheap P/E 16.60x
PEG 0.49x
EV/EBITDA 9.15x
Growth
62 /100
Stable EPS growth 15.11%
Book val. growth 5.34%
Rev. growth 4.06%
Profitability
78 /100
Strong Gross margin 56.10%
FCF margin 12.04%
Net margin 13.26%
Quality
70 /100
Excellent ROIC 11.03%
Asset turnover 0.71x
ROE 17.61%
Debt
100 /100
Low Debt/Equity 0.10x
Net debt/EBITDA -0.72x
Current ratio 2.82x
Stability
38 /100
Moderate Beta 0.24x
Profitable years 2
Rev. volatility 4.47%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SNPHF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Takeshi Ito
Employees
3,968
Headquarters
Kita
Prihajajoči dogodki
29 SEP.
Ex-Dividend
Ex-dividend date
29 SEP.
Dividend Payment
Datum plačila
05 NOV.
Earnings
Upcoming earnings report
30 MAR.
Ex-Dividend
Ex-dividend date
30 MAR.
Dividend Payment
Datum plačila